The first goal (Aim 1) of this clinical trial is to learn about specific strengths, challenges, and desired areas of knowledge and skill-building among older adults who re-entered their communities from a period of incarceration and to then develop a new psychoeducational intervention tailored to these older adults. The second goal (Aim 2) of this clinical trial is to test if the intervention increases chronic disease management and whether the intervention is considered appropriate and acceptable by older adults who re-entered their communities from a period of incarceration. Aim 1 participants will: * complete a baseline survey * participate in a focus group Aim 2 participants will: * complete a baseline survey * participate in an 8-week once weekly intervention * complete three follow up surveys
Chronic Disease
The first goal (Aim 1) of this clinical trial is to learn about specific strengths, challenges, and desired areas of knowledge and skill-building among older adults who re-entered their communities from a period of incarceration and to then develop a new psychoeducational intervention tailored to these older adults. The second goal (Aim 2) of this clinical trial is to test if the intervention increases chronic disease management and whether the intervention is considered appropriate and acceptable by older adults who re-entered their communities from a period of incarceration. Aim 1 participants will: * complete a baseline survey * participate in a focus group Aim 2 participants will: * complete a baseline survey * participate in an 8-week once weekly intervention * complete three follow up surveys
Supporting Resilience Among Re-entered Seniors
-
New Legacy Reentry, Louisville, Kentucky, United States, 40203
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
45 Years to
MALE
Yes
University of Louisville,
2024-11-30